Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: inside layer (24), coating (68), liner (5)

Carboplatin(AUC5)-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Carboplatin (AUC5)-Paclitaxel (21 day) Indication • Neoadjuvant treatment of cervical
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/CarboplatinAUC5-Paclitaxel-21day.pdf

SoAR RLP Deputy Lead Role JD and PS

Description: Southampton Academy of Research (SoAR) Research Leaders Programme (RLP) Deputy Lead: Call for expressions of interest University of Southampton NHS Foundation
Url: /Media/Southampton-Clinical-Research/Downloads/SoAR-RLP-Deputy-Lead-Role-JD-and-PS.pdf

Expressions of interest in SoAR Associate Director role JD and PS 24-4-2023

Description: Southampton Academy of Research (SoAR) Associate Director: Call for expressions of interest University of Southampton NHS Foundation Trust (UHSFT) and University
Url: /Media/Southampton-Clinical-Research/Downloads/Expressions-of-interest-in-SoAR-Associate-Director-role-JD-and-PS-24-4-2023.pdf

Workforce demographic 2023

Description: UHS Workforce Profile as of 31st March 2023 UHS is one of the largest employers in Southampton, with 13,704 staff
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/Workforce-demographic-2023.pdf

Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel(14) Ver1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXELACCELERATED Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel (accelerated) Indication • Neoadjuvant / adjuvant therapy of early breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel-14.pdf

ClofarabineCytarabine

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA ALL CLOFARABINE-CYTARABINE In-Patient Regimen Clofarabine not licensed in adult patients. This may require funding
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/ClofarabineCytarabine.pdf

Ceritinib 450mg

Description: Ceritinib
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Ceritinib-450mg.pdf

Cisplatin (70) Gemcitabine ver1.1

Description: Chemotherapy Protocol BLADDER CISPLATIN (70)-GEMCITABINE Regimen Bladder-Cisplatin (70)-Gemcitabine Indication First line treatment of locally advanced or metastatic urothelial
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-70-Gemcitabine-ver1.1.pdf

Axitinib v1.2

Description: Chemotherapy Protocol RENAL CELL AXITINIB This regimen may require funding Regimen Renal Cell - Axitinib Indication Second line treatment of advanced or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Axitinib-v1.2.pdf

Papers Council of Governors - 26 January 2022

Description: Agenda attachments 1 CoG Agenda - 26.01.2022.docx Date Time Location Chair Agenda Council of Governors 26/01/2022 14
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Council-of-Governors-26-January-2022.pdf

291 to 300 of 748

Previous … 28 29 30 31 32 … Next